期刊文献+

前哨淋巴结活检术在N0期阴茎癌的临床意义 被引量:1

The clinical significance of Sentinel lymph node biopsy in N0 penile cancer
下载PDF
导出
摘要 背景与目的:阴茎癌在原发病灶切除后是否行腹股沟淋巴结清扫术一直存在争议,本文旨在探讨前哨淋巴结活检术(sentinel lymph node biopsy,SLNB)在无肿大淋巴结的pN0期阴茎癌患者中的可行性及临床意义。方法:回顾性分析军事医学科学院附属医院泌尿外科2004年3月—2012年08月收治的25例pN0期阴茎癌患者的临床资料,切除原发病灶后均利用亚甲蓝蓝染,并同时行改良的腹股沟淋巴结清扫术(inguinallymph node dissection,ILND)。结果:前哨淋巴结(sentinel lymph node,SLN)实际检测出24例,成功率为96%(24/25),阳性7例,阴性17例;本组准确率为95.8%(23/24),灵敏度为87.5%(7/8),假阴性率为12.5%(1/8),无假阳性。SLNB病理结果与常规病理结果比较具有高度一致性(Kappa value=0.903,P<0.01)。结论:目前SLNB对于pN0期阴茎癌患者是否行淋巴结清扫术仍具有重要的的指导意义。 Background and purpose: The inguinal lymph node dissection of penile cancer after resection of the primary lesion has been controversial, this paper aimed to preliminary study the feasibility and clinical significance of sentinel lymph node biopsy (SLNB) in pN0 stage patients with penile cancer. Methods: We analyzed retrospectively the clinical data of 25 patients of pN0 penile cancers admitted in our department from Mar. 2004 to Aug. 2012, all the patients used the methylene blue for SLNB after having resection of the primary lesion, at the same time received modified inguinal lymph node dissection (ILND). Results: The sentinel lymph node (SLN) of 24 patients had be actually detected, the success rate was 96% (24/25), 7 was positive, 17 was negative; The accuracy was 95.8% (23/24), sensitivity was 87.5% (7/8), false negative rate was 12.5% (1/8), and no false positive. There is a high degree of consistency between the SLNB grope and the routine grope (Kappa value=0.903, P〈0.01). Conclusion: SLNB for pN0 stage penile cancers without swollen lymph node had still important guiding significance.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2013年第5期353-356,共4页 China Oncology
关键词 阴茎癌 前哨淋巴结 淋巴结清扫术 Penile cancer Sentinel lymph node Lymph node dissection
  • 相关文献

参考文献11

  • 1CABANAS R M. An approach for the treatment of penile carcinoma [ J ]. Cancer, 1977, 39(2): 456-466.
  • 2KROON B K, HORENBLAS S, LONT A P, et al. Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases [ J ]. J Urol, 2005,173(3): 816-819.
  • 3BUCHER S, GUERRA M, RIBUFFO D. Selective lymphadenectomy for penile cancer [ J ] . Eur Rev Med Pharmacol Sci, 2011, 15(8): 967-970.
  • 4SADEGHI R, GHOLAMI H, ZAKAVI S R, et al. Accuracy of sentinel lymph node biopsy for inguinal lymph node staging of penile squamous cell carcinoma: systematic review and meta- analysis of the literature [ J ] . J Urol, 2012, 187(1): 25-31.
  • 5YEUNG L L, BRANDES S B. Dynamic sentinel lymph node biopsy as the new paradigm for the management of penile cancer [ J ] . Urol Oncol, 2012. [ Epub ahead of print ] .
  • 6HORENBLAS S. Sentinel lymph node biopsy in penile carcinoma [ J ] . Semin Diagn Pathol, 2012, 29(2): 90-95.
  • 7ALEXANDER R E, SUNG M T, CHENQ L. Lymphadenectomy in urologic oncology: pathologic considerations [ J 1 Urol Clin North Am, 2011, 38(4): 483-495.
  • 8LAM W, ALNAJJAR H M, LA-TOUCHE S, et al.Dynamic sentinel lymph node biopsy in patients with invasive squamous cell carcinoma of the penis: A prospective study of the long-term outcome of 500 inguinal basins assessed at a single institution [ J ]. Eur Urol, 2012, 63(4): 657-663.
  • 9KIRRANDER P, ANDREN O, WINDAHL T. Dynamic sentinel node biopsy in penile cancer: initial experiences at a Swedish referral centre [ J ] . BJU Int, 2013, 111(3): 48-53.
  • 10LEIJTE J A, VALDIS OLMOS R A, NIEWEG O E, et al. Anatomical mapping of lymphatic drainage in penile carcinoma with SPECT-CT: implications for the extent of inguinal lymph node dissection [ J ]. Eur Urol, 2008, 54(4): 885-890.

同被引文献12

  • 1David N Krag,Stewart J Anderson,Thomas B Julian,Ann M Brown,Seth P Harlow,Joseph P Costantino,Takamaru Ashikaga,Donald L Weaver,Eleftherios P Mamounas,Lynne M Jalovec,Thomas G Frazier,R Dirk Noyes,André Robidoux,Hugh MC Scarth,Norman Wolmark.Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial[J]. Lancet Oncology . 2010 (10)
  • 2Marcinow A M,Hall N,Byrum E,et al.Use of a NovelReceptor-Targeted (CD206) Radiotracer,99mTc-Tilmanocept,andSPECT/CT for Sentinel Lymph Node Detection in Oral Cavity SquamousCell Carcinoma:Initial Institutional Report in an Ongoing Phase3Study. JAMA Otolaryngology–Head&NeckSurgery . 2013
  • 3Wernicke A Gabriella,Shamis Michael,Sidhu Kulbir K,Turner Bruce C,Goltser Yevgenyia,Khan Imraan,Christos Paul J,Komarnicky-Kocher Lydia T.Complication Rates in Patients With Negative Axillary Nodes 10 Years After Local Breast Radiotherapy After Either Sentinel Lymph Node Dissection or Axillary Clearance. American journal of clinical oncology . 2011
  • 4Fields Ryan C,Busam Klaus J,Chou Joanne F,Panageas Katherine S,Pulitzer Melissa P,Kraus Dennis H,Brady Mary S,Coit Daniel G.Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Annals of Surgical Oncology . 2011
  • 5Sandra L. Wong,Michael J. Edwards,Celia Chao,Todd M. Tuttle,R. Dirk Noyes,David J. Carlson,Alison L. Laidley,Terre Q. McGlothin,Philip B. Ley,C. Matthew Brown,Rebecca L. Glaser,Robert E. Pennington,Peter S. Turk,Diana Simpson,Kelly M. McMasters.??The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy(J)Annals of Surgical Oncology . 2002 (3)
  • 6Min Yi,Sharon Hermes Giordano,Funda Meric-Bernstam,Elizabeth A. Mittendorf,Henry M. Kuerer,Rosa F. Hwang,Isabelle Bedrosian,Loren Rourke,Kelly K. Hunt.??Trends in and Outcomes from Sentinel Lymph Node Biopsy (SLNB) Alone vs. SLNB with Axillary Lymph Node Dissection for Node-Positive Breast Cancer Patients: Experience from the SEER Database(J)Annals of Surgical Oncology . 2010 (3)
  • 7王亚楠,李国新.前哨淋巴结导航在胃癌手术中的运用现状[J].中华胃肠外科杂志,2011,14(1):76-77. 被引量:7
  • 8王志华,熊钰芬,徐汉玲,刘双林.阴茎癌是否一期行腹股沟淋巴结清扫[J].现代泌尿生殖肿瘤杂志,2010,2(6):374-375. 被引量:3
  • 9陆晓娜.乳腺癌前哨淋巴结活检研究进展[J].中国医学创新,2011,8(16):181-184. 被引量:6
  • 10覃俊仕,罗汉传,吴瑞正,滕奔宇,吴志懂.亚甲蓝示踪法在乳腺癌前哨淋巴结活检中的临床应用[J].肿瘤药学,2012,2(6):456-459. 被引量:5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部